Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes

The recruitment status of this study is unknown because the information has not been verified recently.

Verified March 2010 by Shanghai Jiao Tong University School of Medicine.
Recruitment status was Recruiting

Sponsor:

Information provided by (Responsible Party):

Guang Ning, Shanghai Jiao Tong University School of Medicine

ClinicalTrials.gov Identifier:

NCT00807651

First received: December 11, 2008

Last updated: March 7, 2012

Last verified: March 2010

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	February 2013
Estimated Primary Completion Date:	January 2013 (Final data collection date for primary outcome measure)

No publications provided by Shanghai Jiao Tong University School of Medicine

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Gu W, Hu J, Wang W, Li L, Tang W, Sun S, Cui W, Ye L, Zhang Y, Hong J, Zhu D, Ning G. Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes. Diabetes Care. 2012 Jul;35(7):1413-9.

Zhang X, Ye L, Hu J, Tang W, Liu R, Yang M, Hong J, Wang W, Ning G, Gu W. Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient. PLoS One. 2012;7(2):e31887. Epub 2012 Feb 22.

To Top